Developing innovative drug delivery technologies to eliminate the burden of multiple daily fertility treatment injections for women.
Latchmi Raghunanan, PhD., Founder & CEO
With a strong foundation in materials science, project management, and product development, Latchmi has spearheaded innovation across academia, industry, and startups. She has secured five patents, developed four MVPs, and is driving a surgical adhesive toward clinical trials.
Known for her ability to break down silos and foster collaboration, Latchmi has led diverse teams and implemented strategies that saved over $700K in pre-revenue cash flow. Drawing from her personal experiences with infertility, she is passionate about creating solutions that center on user experience, accessibility, and compassion in reproductive health.
Latchmi’s leadership reflects her commitment to revolutionizing healthcare for women and addressing the unique challenges of scaling innovation in FemTech.
SDG 3: Good Health and Well-Being;SDG 5: Gender Equality;SDG 8: Decent Work and Economic Growth;SDG 10: Reduced Inequalities
Website